RHÖN-KLINIKUM Toekomstige groei
Future criteriumcontroles 1/6
RHÖN-KLINIKUM is forecast to grow earnings and revenue by 5.1% and 2% per annum respectively. EPS is expected to grow by 8.3% per annum. Return on equity is forecast to be 3.4% in 3 years.
Belangrijke informatie
5.1%
Groei van de winst
8.3%
Groei van de winst per aandeel
Healthcare winstgroei | 23.1% |
Inkomstengroei | 2.0% |
Toekomstig rendement op eigen vermogen | 3.4% |
Dekking van analisten | Low |
Laatst bijgewerkt | 17 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
RHÖN-KLINIKUM Aktiengesellschaft's (ETR:RHK) Business Is Trailing The Market But Its Shares Aren't
Jun 26RHÖN-KLINIKUM (ETR:RHK) Seems To Use Debt Rather Sparingly
Apr 25RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Mar 02Is RHÖN-KLINIKUM (ETR:RHK) Using Too Much Debt?
Dec 19Here's Why RHÖN-KLINIKUM (ETR:RHK) Can Manage Its Debt Responsibly
Jul 13There Are Reasons To Feel Uneasy About RHÖN-KLINIKUM's (ETR:RHK) Returns On Capital
Jun 15These 4 Measures Indicate That RHÖN-KLINIKUM (ETR:RHK) Is Using Debt Reasonably Well
Sep 20Capital Allocation Trends At RHÖN-KLINIKUM (ETR:RHK) Aren't Ideal
Aug 11Robust Earnings May Not Tell The Whole Story For RHÖN-KLINIKUM (ETR:RHK)
Apr 01Does RHÖN-KLINIKUM (ETR:RHK) Have A Healthy Balance Sheet?
May 14Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 1,657 | 50 | 28 | 107 | 2 |
12/31/2025 | 1,596 | 44 | 25 | 99 | 2 |
12/31/2024 | 1,534 | 39 | 39 | 110 | 2 |
6/30/2024 | 1,802 | 47 | 69 | 142 | N/A |
3/31/2024 | 1,767 | 43 | N/A | N/A | N/A |
12/31/2023 | 1,735 | 39 | 46 | 109 | N/A |
9/30/2023 | 1,713 | 32 | N/A | N/A | N/A |
6/30/2023 | 1,694 | 26 | -11 | 43 | N/A |
3/31/2023 | 1,690 | 30 | N/A | N/A | N/A |
12/31/2022 | 1,661 | 25 | 2 | 60 | N/A |
9/30/2022 | 1,640 | 30 | N/A | N/A | N/A |
6/30/2022 | 1,628 | 32 | -18 | 48 | N/A |
3/31/2022 | 1,602 | 28 | N/A | N/A | N/A |
12/31/2021 | 1,591 | 28 | 20 | 98 | N/A |
9/30/2021 | 1,557 | 15 | N/A | N/A | N/A |
6/30/2021 | 1,554 | 14 | 23 | 117 | N/A |
3/31/2021 | 1,549 | 7 | N/A | N/A | N/A |
12/31/2020 | 1,546 | 1 | 16 | 113 | N/A |
9/30/2020 | 1,537 | 8 | 20 | 113 | N/A |
6/30/2020 | 1,532 | 19 | 10 | 100 | N/A |
3/31/2020 | 1,513 | 31 | -28 | 63 | N/A |
12/31/2019 | 1,481 | 43 | -67 | 47 | N/A |
9/30/2019 | 1,436 | 40 | -61 | 91 | N/A |
6/30/2019 | 1,413 | 52 | -95 | 74 | N/A |
3/31/2019 | 1,394 | 47 | -134 | 46 | N/A |
12/31/2018 | 1,390 | 49 | -114 | 50 | N/A |
9/30/2018 | 1,411 | 55 | -114 | 24 | N/A |
6/30/2018 | 1,385 | 36 | -76 | 54 | N/A |
3/31/2018 | 1,374 | 37 | N/A | 63 | N/A |
12/31/2017 | 1,362 | 35 | N/A | 80 | N/A |
9/30/2017 | 1,340 | 2 | N/A | 69 | N/A |
6/30/2017 | 1,330 | 4 | N/A | 87 | N/A |
3/31/2017 | 1,334 | 14 | N/A | 96 | N/A |
12/31/2016 | 1,319 | 56 | N/A | 109 | N/A |
9/30/2016 | 1,291 | 101 | N/A | 114 | N/A |
6/30/2016 | 1,276 | 105 | N/A | 101 | N/A |
3/31/2016 | 1,251 | 103 | N/A | 80 | N/A |
12/31/2015 | 1,240 | 85 | N/A | 67 | N/A |
9/30/2015 | 1,250 | 66 | N/A | 63 | N/A |
6/30/2015 | 1,248 | 62 | N/A | 54 | N/A |
3/31/2015 | 1,300 | -138 | N/A | 55 | N/A |
12/31/2014 | 1,666 | 1,226 | N/A | 49 | N/A |
9/30/2014 | 2,171 | 1,245 | N/A | 67 | N/A |
6/30/2014 | 2,661 | 1,250 | N/A | 153 | N/A |
3/31/2014 | 3,098 | 1,459 | N/A | 209 | N/A |
12/31/2013 | 3,223 | 87 | N/A | 210 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: RHK's forecast earnings growth (5.1% per year) is above the savings rate (0.8%).
Winst versus markt: RHK's earnings (5.1% per year) are forecast to grow slower than the German market (20.1% per year).
Hoge groeiwinsten: RHK's earnings are forecast to grow, but not significantly.
Omzet versus markt: RHK's revenue (2% per year) is forecast to grow slower than the German market (5.5% per year).
Hoge groei-inkomsten: RHK's revenue (2% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: RHK's Return on Equity is forecast to be low in 3 years time (3.4%).